MARSICO CAPITAL MANAGEMENT, LLC – Trademark Portfolio

Entity Type: 16

MARSICO CAPITAL MANAGEMENT, LLC holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 7 filings in this category. Currently, 5 trademarks are registered. Notable registered marks include MARSICO FUNDS, MARSICO INVESTMENT FUND, HELPING YOU APPRECIATE LIFE, and MARSICO CAPITAL MANAGEMENT, LLC. The owner is based in Denver, CO.

1200 17th Street, Suite 1300

Denver, CO 80202

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

MARSICO CAPITAL MANAGEMENT, LLC's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (7 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademarks does MARSICO CAPITAL MANAGEMENT, LLC have?

MARSICO CAPITAL MANAGEMENT, LLC has 7 U.S. trademarks filed with the USPTO. Of these, 5 registered, 2 cancelled.

What trademark classes does MARSICO CAPITAL MANAGEMENT, LLC file in?

MARSICO CAPITAL MANAGEMENT, LLC files trademarks across 1 Nice Classification class. The most active classes are Class 36 (Insurance & Financial). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What are MARSICO CAPITAL MANAGEMENT, LLC's most well-known trademarks?

MARSICO CAPITAL MANAGEMENT, LLC's registered trademark portfolio includes well-known marks such as MARSICO FUNDS, MARSICO INVESTMENT FUND, HELPING YOU APPRECIATE LIFE, and MARSICO CAPITAL MANAGEMENT, LLC. These are among 5 currently registered trademarks in the portfolio.

What is MARSICO CAPITAL MANAGEMENT, LLC's trademark registration success rate?

MARSICO CAPITAL MANAGEMENT, LLC has a 71% trademark registration rate, with 5 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.